(800) 369-0899
(215) 569-4000

Contact Us Today



← Older posts

Immunotherapy and Radiation Trial

Immunotherapy is changing the landscape of cancer treatment. Whether on its own or in conjunction with other therapies, immunotherapy gives patients’ bodies the tools they need to destroy cancer cells. Each disease has unique markers that must be identified for a targeted treatment to be developed. Once researchers get on the right track, the results » Read More

Targeted Social Media to Expand Mesothelioma Knowledge

Information is power, and more and more people receive the bulk of their information from social media. Mesothelioma researchers are using social media to inform people exposed to asbestos about their risks, as well as to let those already diagnosed with the disease know about clinical trials and new treatment options. There is also hope » Read More

Targeting Lymph Nodes

Mesothelioma is a particularly difficult to treat cancer that develops from exposure to asbestos. While a recent discovery does not offer a new avenue to a cure, it does offer potential new insight into diagnosis, staging, and treatment options for this terrible disease. Clinical Trial Discovers Posterior Intercostal Lymph Nodes Link Fifty-six mesothelioma patients were » Read More

Combining Chemotherapy and TroVax for Mesothelioma Treatment

Recent studies indicate the effectiveness of a potential new treatment option for mesothelioma patients. According to research, when patients received a combination of chemotherapy treatments and TroVax, immune responses were boosted. The study results indicate a potential new option for those suffering from this aggressive cancer. What is TroVax? TroVax is a cancer vaccine that » Read More

← Older posts